Data provide first human validation of cardiac energetics modulation as a therapeutic target in cardiometabolic heart disease, including heart ...

Data provide first human validation of cardiac energetics modulation as a therapeutic target in cardiometabolic heart disease, including heart failure with preserved ejection fraction (HFpEF) In ...

Data provide first human validation of cardiac energetics modulation as a therapeutic target in cardiometabolic heart disease, including heart failure with preserved ejection fraction (HFpEF) ...

Polygenic background bidirectionally modifies the penetrance of pathogenic variants in hypertrophic (HCM) and dilated (DCM) ...

According to a recent study, in heart failure with reduced ejection fraction (HFrEF) patients, elevated high-sensitivity ...

A meta-analysis of recent clinical trials evaluating β-blockers as treatment for patients with acute myocardial infarction ...

The market underappreciates TENX's late-stage pipeline and risk-adjusted asset value; we recommend buying ahead of Phase 3 ...

Newly diagnosed patients with KRAS G12C-mutant advanced or metastatic nonsquamous NSCLC will be enrolled in the trial.

Background The National Heart Failure Audit gathers data on patients coded at discharge (or death) as having heart failure as ...

Type 2 diabetes physically alters heart muscle, energy use and structure, a human heart study finds, explaining why people ...

Clinical trials underrepresent women, children, and adults aged 65 years or older, so diabetes guidelines must be adapted to ...

The body needs iron to deliver oxygen throughout the body. Iron supplements can help improve many conditions, such as anemia ...